Non-Nucleoside Reverse Transcriptase Inhibitors (Boehringer Ingelheim)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNon-Nucleoside Reverse Transcriptase Inhibitors (Boehringer Ingelheim)
Drug Alias Namenevirapine analogs (Boehringer Ingelheim)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim Corp
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A